Click' Login' then 'Don't have an Account ' and join $$Lounge for free

True Leaf Medicine International - MJ:CSE

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
1 month 2 weeks ago #120258 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
2 months 2 weeks ago #119886 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
Now's the time to get into this one if you don't own any IMO. It peaked at $1.90 and has had its 50% retracement. They just raised $14M, are revenue producing with hemp-based pet food products, and are starting phase one of what will ultimately be a 1 million square foot production facility in B.C. CEO Darcy Bomford is the real deal: www.ganjapreneur.com/darcy-bomford-acqui...s-license-in-canada/

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
2 months 3 weeks ago #119849 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
True Leaf Completes Purchase of 40-Acre Site for Cannabis Production

Phase One Construction Plan Includes a 25,000 Square Foot Hydroponic Medicinal Cannabis Production Facility in Lumby, BC

Vernon, British Columbia--(Newsfile Corp. - January 30, 2018) - True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF) ("True Leaf"), a quality of life cannabis company for people and their pets, has completed the purchase of 40 acres of land that encompasses the site of its facility in Lumby, British Columbia, Canada, through its wholly owned subsidiary True Leaf Medicine Inc.

The purchase was finalized on January 19, 2018 at a total cost of $3.3 million CAD.

True Leaf, as previously announced, closed a $10 million Regulation A+ offering and a concurrent $4 million non-brokered private placement financing with Canadian investors only. True Leaf is the first Canadian-listed company to conduct a success Regulation A+ offering.

The company used a portion of the proceeds from the offerings to complete the purchase of the Lumby site. Additional offering proceeds will be used to build and staff phase one of the True Leaf facility, as well as provide working capital for the True Leaf Pet business.

True Leaf's application to produce and distribute cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) has completed the security clearance stage, and the company has permission to build its production facility. At this time, True Leaf does not have a license to produce cannabis.

True Leaf expects phase one: the construction of a 16,000 square foot hydroponic grow building and a 9,000 square foot building housing offices, extraction facility, laboratory and packaging areas to be completed by the end of summer 2018, with a first crop produced in the fall of 2018. True Leaf's first crop will be required to pass a Health Canada inspection in order for True Leaf to be granted a license to grow medicinal cannabis.

Commenting on this latest milestone, True Leaf CEO Darcy Bomford said, "The company is pleased with the completion of our offerings and the purchase of the land and we can move forward in our pursuit of growing what we hope will be the best quality medicinal cannabis in the world."

True Leaf plans to become a one of the main employers in Lumby, a logging community of 1,700 in the northeast corner of the Okanagan Valley in southern British Columbia.

About True Leaf

Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. The Company's goal is to provide federally-approved, safe and effective cannabis products that will be sold across Canada and the United States. True Leaf Medicine Inc. was launched in July 2013 to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been given approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion to allow for the cultivation, manufacture, and distribution of cannabis products. Currently, True Leaf does not have a license to produce cannabis.

Established in 2015, True Leaf Pet Inc. markets safe, hemp-focused products for the pet industry. The Company launched the True Hemp™ pet supplement line in Canada, the United States, and Europe, becoming one of the first hemp-based pet product lines to be marketed worldwide. True Hemp™ North American products are free of CBD and THC, making them the first federally legal products to be marketed in Canada and the United States.

www.trueleaf.com

Media Contact:

Paul Sullivan
Director, Public Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
O: 604-685-4742
M: 604-603-7358

Investor Contact:

Kevin Bottomley (Canada)
Director and Corporate Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
M: 778-389-9933

Tirth Patel (US)
Edison Advisors
This email address is being protected from spambots. You need JavaScript enabled to view it.
O: 646-653-7035

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
2 months 3 weeks ago #119848 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
True Leaf Raises a Total $14 Million (CAD) of Equity Financing

VERNON, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf” or the “Company”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), the quality of life cannabis company for people and their pets, today announced that it has raised $10 million (CAD) through a Regulation A+ public equity offering, two months after the U.S. Securities and Exchange Commission (SEC) qualified its offering statement.

True Leaf also announced today it is in the process of closing a $4,051,654.60 non-brokered private placement selling 5,788,078 common shares at a price of C$0.70 per share to Canadian investors only. All securities issued pursuant to the Canadian offering are subject to a statutory hold period of four months and one day.

In the Regulation A+ offering, True Leaf offered a total of 14,285,715 common shares at a price of C$0.70 per share, with a minimum subscription amount of C$350 (or 500 shares) per investor. The use of Regulation A+ allowed the Company to offer and sell its common shares to public retail investors as well as traditional accredited and institutional investors.

With the offering fully closed, True Leaf is the first Canadian-listed company to conduct a successful Regulation A+ offering.

“We’ve always wanted to give the people who love our products, and share in our vision and values, the chance to own a piece of True Leaf,” said Darcy Bomford, Founder and Chief Executive Officer of True Leaf. “Regulation A+ gave us this opportunity. We believe the proceeds from this offering should put us in an excellent position to execute our business plan and accelerate our growth.”

Boustead Securities, LLC (“Boustead”), working with its affiliate, FlashFunders™, is the lead underwriter and bookrunner for the offering. CrowdfundX™ is the digital marketing agency of record.

“I believe True Leaf had some of the ingredients for a successful Regulation A+ equity placement, including offering a product in an emerging market segment of interest to many, and a plan to distribute the securities to different types of investors, some of whom may not have had an opportunity to participate in such offerings before the crowdfunding regulations were enacted,” added Keith Moore, Chief Executive Officer of Boustead.

“We saw what we believe to have been exceptional engagement and click-through rates on the crowdfund campaign, which, in our opinion, was a result of extensive planning and collaboration,” stated Darren Marble, Chief Executive Officer of CrowdfundX.

About True Leaf

Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. The Company’s goal is to provide federally-approved cannabis products that will be sold across Canada and the United States. True Leaf Medicine Inc. was launched in July 2013 to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been granted approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion to allow for the cultivation, manufacture, and distribution of cannabis products. Currently, True Leaf does not have a license to produce cannabis.

Established in 2015, True Leaf Pet Inc. markets hemp-based products for the pet industry. The Company launched the True Hemp™ pet supplement line in Canada, the United States, and Europe, becoming one of the first hemp-based pet product lines to be marketed worldwide. True Hemp™ North American products are free of CBD and THC.

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
3 months 2 weeks ago #119748 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
True Leaf hit $1.90 today making it at least a five bagger from when I first mentioned it here at 35 cents. There's a lot more to go. And I predict that the pet food side, which is huge, expanding internationally, and generating revenue will be spun out to shareholders at some point. The Chairman of the BOD is the Ex-Premier of British Columbia and from the same party as the current newly elected Premier. True Leaf has plans to become the largest producer and distributor in B.C.

True Leaf Exercises Option to Purchase 40-Acre Site in Lumby, B.C. to Build Cannabis Production Facility

True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), has exercised its option to purchase 40 acres of land that encompasses its facility in Lumby, B.C. through its wholly owned subsidiary True Leaf Medicine Inc.

The option was exercised on December 22, 2017 at a total cost of $3.3 million CAD. An up-front fee of $100,000 CAD was paid to the vendor for the purpose of securing the option. True Leaf now has 30 days from that date to complete the purchase.

On November 30, 2017, True Leaf launched its Regulation A+ offering to raise $10 MM CAD that was qualified by the Securities Exchange Commission (SEC). This offering enables underwriters to solicit orders from the general public in addition to traditional accredited investors and institutional investors. The company will use a portion of the funds raised from the offering to build phase one of the True Leaf facility. Boustead Securities, LLC is serving as lead underwriter for the offering.

True Leaf's application to produce and distribute cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) has completed the security clearance stage, and the company has permission to build a production facility.

True Leaf anticipates that the first phase of the build will include annual production of 2,500 kilograms of dried cannabis once the facility passes Health Canada's inspection and the company becomes a licensed producer.

Now that the option has been exercised, True Leaf's ownership of the land will allow it to go ahead with plans to demolish an existing building to make way for phase one: the construction of a 16,000-square foot hydroponic grow building and a 9,000-sq. ft. building housing offices, extraction facility, laboratory and packaging areas.

The Company expects site and foundation work to begin in the coming weeks to be completed by summer 2018. The Government of Canada is committed to legalizing marijuana for recreational purposes by July 2018.

Commenting on this latest milestone, CEO Darcy Bomford said, "In addition to purchasing the 40 acres of land to build our facility, the proceeds of the Regulation A+ offering will also be used to acquire the best talent and technology available to help us fulfill our commitment to producing premium products".

True Leaf benefits from the support expressed for the company's license submission by the Mayor of Lumby Kevin Acton, and the community. The company expects to become a significant employer in Lumby, a hard-hit logging community of 1,700 in the northeast corner of the Okanagan Valley in southern British Columbia.

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
4 months 3 weeks ago #119571 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
True Leaf now a triple at 90 cents. WAY OVERSUBSCRIBED on first day of offering!

Raised
$14,265.35 USD

Offering Max
$7,870,608 USD

SEC Qualifies True Leaf Offering for Equity Crowdfunding

VERNON, BC – (November 30, 2017) – True Leaf Medicine International Ltd. (“True Leaf” or the “Company”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), announced today that it has received a notice of qualification from the Securities and Exchange Commission (“SEC”) of its Regulation A+ Tier 2 Offering Statement under Title IV of the JOBS Act to raise up to $10 million CAD in an offering that launches today.
 
True Leaf’s Regulation A+ offering enables underwriters to solicit orders from the general public in addition to traditional accredited investors and institutional investors. The SEC qualified the Offering Statement on November 21, 2017. The Company is offering a maximum of 14,285,715 common shares at a price of $0.70 CAD per share, with a minimum subscription amount of $350 (or 500 shares) per investor.
 
In addition to traditional marketing methods used in public offerings, this offering is being marketed to online investors via invest.trueleaf.com.
 
Founded in 2013, True Leaf has applied to become a licensed producer of medicinal marijuana and has received Health Canada’s approval to build a production facility on a 40-acre site in Lumby, British Columbia, Canada. The facility is expected to have a production capacity of more than 2,500 kilograms of dried cannabis per year when phase one of the project is completed and approved by Health Canada.
 
Launched in 2015, True Leaf Pet, a subsidiary of True Leaf, developed the True Hemp™ brand and became one of the first hemp-based pet product lines to be marketed worldwide. True Hemp™ formulations combine the properties of hemp seed with other active ingredients that support multiple functions in a soft chew, stick, and oil supplement format. The Company has tripled its product line over the past nine months and has seen rapid growth in the United States, Canada, and Europe, with a seven-fold increase in sales for the first quarter of 2017 compared to the same quarter last fiscal year.
 
“We are excited about gaining SEC qualification for our Regulation A+ offering,” said True Leaf founder and Chief Executive Officer Darcy Bomford. "It has been a remarkable nine-month journey and now we’re able to extend a unique opportunity to own a piece of True Leaf to customers, supporters, and investors who share our values and enthusiasm for the potential of our products.”
 
For more information on investing in True Leaf, please visit invest.trueleaf.com.
 
SEC Legends
An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement, which only means that we may make sales of the securities described by the offering statement. It does not mean that the SEC has approved, passed upon the merits, or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement from: HERE

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
6 months 3 weeks ago #118986 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
Closed at .75 today a 150% increase since my original post in June. News today:

True Leaf Medicine acquires option to buy land in B.C.
2017-09-28 07:54 ET - News Release

Mr. Darcy Bomford reports

TRUE LEAF ACQUIRES OPTION TO PURCHASE 40-ACRE SITE IN LUMBY, B.C. TO BUILD CANNABIS PRODUCTION FACILITY

True Leaf Medicine International Ltd. has acquired an option to purchase the 40 acres of land that encompasses its facility in Lumby, B.C., through its wholly owned subsidiary True Leaf Medicine Inc.

The option is exercisable until Dec. 31, 2017, at a total cost of $3.3-million, $100,000 of which has already been paid to the vendor in the form of an upfront fee for the purpose of securing the option.

True Leaf's application to produce and distribute cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) has completed the security clearance stage and the company has initiated plans to refit the 16,000-square-foot building on the property. Upon exercise, True Leaf's ownership of the property will allow the company to rapidly expand operations once it is approved as a licensed producer from Health Canada.

"This is a milestone for True Leaf," commented chief executive officer Darcy Bomford. "This property gives us the capacity to expand to meet the increased demand that is widely expected. With government approvals, the size of this site could allow us to build a one-million-square-foot facility and produce more than 125,000 kilograms of cannabis."

True Leaf anticipates that the first phase will include annual production of 2,500 kilograms of dried cannabis once the facility passes Health Canada's inspection and the company becomes a licensed producer.

"True Leaf appreciates the support expressed for the company's licence submission by the Mayor of Lumby, Kevin Acton, and the community," continued Mr. Bomford. "We expect to become a significant employer in Lumby, a hard-hit logging community of 1,700 in the northeast corner of the Okanagan Valley in Southern British Columbia."

This significant company milestone comes at a time that True Leaf is preparing to launch a $10-million round of financing using the Regulation A plus model in the United States and corresponding exemptions from the prospectus requirements in Canada.

About True Leaf Medicine International Ltd.

True Leaf Medicine International, through its wholly owned subsidiary True Leaf Pet, has entered the $104.9-billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States, New Zealand and Europe. The company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its True Leaf Medicine subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting approval to build its installation in British Columbia, Canada.

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
6 months 4 weeks ago #118968 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE
It took just over three months for the share price to double (closed at .60 today) from my original post. Lots of news to come re the production license and while shareholders wait pet food sales are really taking off: True Leaf Pet Expands Selling Power In-Store and Online
Hemp-based supplements now available on Amazon.com, WholesalePet.com, and in 415 Pet Supplies Plus stores across the U.S.

Vancouver, Canada – (September 6, 2017) – True Leaf Pet, a division of True Leaf Medicine International Ltd. (MJ: CSE) (TLA: FSE) (TRLFF: OTCQB), has – in the span of a week – significantly expanded the distribution of its popular True Hemp™ supplement line both online and in bricks and mortar stores.
Over the last seven days, True Leaf Pet has begun selling its hemp-based canine supplements direct to consumers on Amazon.com, to retailers on WholesalePet.com, and in 415 specialty stores of Pet Supplies Plus.
The three agreements immediately improve True Leaf Pet’s ability to increase sales of its already successful product line.
The deal with Pet Supplies Plus will see True Leaf Pet products sold in the company’s corporate and strong-performing franchise stores in 29 U.S. states. According to Pet Supplies Plus, a franchise store averages annual sales of US $2,358,431. This agreement brings the total number of stores now offering True Leaf Pet products to 1,500 worldwide.
True Leaf Pet’s online expansion is equally significant. Amazon has become a dominant force in the pet product sector. In 2016, sales of pet products on Amazon were US $2 billion dollars, an increase of 40 per cent over 2015. Not incidentally, U.S. online pet product sales have increased 45 per cent over the last two years.
WholesalePet.com, established in 2001, is a free online buying service connecting pet retailers with top brands such as True Leaf Pet.
The agreements with Pet Supplies Plus and Amazon are the latest benefits of True Leaf Pet’s partnership established earlier this year with Chuck Latham Associates Inc. (CLA). CLA is the leading firm in the pet specialty market providing coverage across all major sales channels, including independent pet stores, farm stores, national pet retailers, and internet retailers.
When the partnership agreement was signed in March, True Leaf CEO Darcy Bomford called CLA the “gold-standard rep-firm in the pet industry”, and CLA Executive Bob Haege said True Leaf Pet was a


Page 2 of 2

great fit for CLA. “We see True Hemp™ as a growth engine for stores looking for a legal and effective product line for hemp-friendly consumers, especially the valuable millennial demographic,” he said.
About True Leaf:
True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States, New Zealand, and Europe. The company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada’s review and is currently awaiting approval to build its installation in British Columbia, Canada.
www.trueleaf.com www.trueleafpet.com

Media Contact:
Paul Sullivan BreakThrough Communications This email address is being protected from spambots. You need JavaScript enabled to view it. O: 604-685-4742 M: 604-603-7358

Investor Contact:
Kevin Bottomley Director and Corporate Relations This email address is being protected from spambots. You need JavaScript enabled to view it. M: 778-389-9933

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
8 months 3 weeks ago #118560 by CIMA
CIMA replied the topic: True Leaf Medicine International - MJ:CSE

Please Log in or Create an account to join the conversation.

  • Hoss
  • Hoss's Avatar
  • Away
  • Premium Member
  • Premium Member
More
10 months 1 week ago #118222 by Hoss
Hoss replied the topic: True Leaf Medicine International - MJ:CSE
Yup agree, going to look into it some more

Please Log in or Create an account to join the conversation.

More
10 months 1 week ago #118219 by Gambler
Gambler replied the topic: True Leaf Medicine International - MJ:CSE
This looks pretty interesting. Seems to have a much more reasonable valuation than a lot of them out there

Please Log in or Create an account to join the conversation.

  • CIMA
  • CIMA's Avatar Topic Author
  • Offline
  • Senior Member
  • Senior Member
More
10 months 1 week ago #118212 by CIMA
CIMA created the topic: True Leaf Medicine International - MJ:CSE
True Leaf Announces Second Tranche Closing of Private Placement

Vancouver, British Columbia--(Newsfile Corp. - June 13, 2017) - True Leaf Medicine International Ltd. (CSE: MJ) (OTC Pink: TLFMF) (FSE: TLA) is pleased to announce that it has closed the second tranche of its recently-announced non-brokered private placement by issuing an aggregate of 4,641,816 units (each, a "Unit") at a price of C$0.30 per Unit for aggregate gross proceeds of C$1,392,545 (the "Private Placement"). Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant exercisable into one Common Share at a price of $0.45 for a period of 24 months. One insider of the Company subscribed for 85,000 Units, representing C$25,500 of the gross proceeds.

In connection with the Private Placement, the Company paid an aggregate of $18,617 in cash commissions to three finders, equal to 7% of the gross proceeds received from investors introduced to the Company by those finders.

The Company intends to use the proceeds of the Private Placement as disclosed in its news release dated May 3, 2017, and in particular, to develop the business of its 'True Leaf Medicine', 'True Leaf Pet' and 'True Leaf Pet Europe' subsidiaries.

All securities issued pursuant to the Private Placement are subject to a statutory hold period of four month and one day.

This press release does not constitute an offer to sell or a solicitation of an offer to buy securities in the United States. The securities referenced herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold in the United States except in compliance with one or more exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws.

About True Leaf:

True Leaf Medicine International Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The Company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (AC(MPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the security screening process of Health Canada's review and is currently in the final review stage before the 'pre-licensing inspection' approval.

For more information, please see the Company's website at www.trueleaf.com .

Investor Contact:
Kevin Bottomley
Director and Corporate Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
M: 778-389-9933

Media Contact:
Paul Sullivan
BreakThrough Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
O: 604-685-4742
M: 604-603-7358

Read more at www.stockhouse.com/news/press-releases/2...#yWZOxr2hr0cVpkHL.99

Please Log in or Create an account to join the conversation.

Time to create page: 0.219 seconds

Login Form